Has Martin Schear, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,204,546 in general payments to Martin Schear, MD across 1,690 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Martin Schear, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Martin Schear, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Martin Schear, MD

Family Medicine · Dayton, OHNPI 1801885355

Payments from drug & device makers

$2,204,546in general payments, 2019–2025

Across 1,690 payments — averaging $1304.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$1.3M
Seqirus USA Inc$312K
Merck$153K
GSK$121K
Novo Nordisk AS$119K
AstraZeneca$87K
plus $147K from 54 others

$1,876in research payments, 2019–2025

Across 10 payments — averaging $187.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sanofi Pasteur Inc.$1K
Otsuka Pharmaceutical Development & Commercialization, Inc.$521

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	574	$1,264,912
Seqirus USA Inc	16	$312,192
Merck	118	$153,145
GSK	136	$120,609
Novo Nordisk AS	36	$119,317
AstraZeneca	203	$87,389
Novavax Inc	23	$60,617
Amgen	16	$15,066
Sanofi US Services Inc.	1	$13,085
Adamis Pharmaceuticals Corporation	5	$10,678
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$8,457
Astrazeneca UK Limited	7	$7,213
Corium, LLC	1	$7,000
Boehringer Ingelheim	25	$5,257
Janssen Research & Development, LLC	1	$4,500
Life Technologies Corporation	1	$4,250
Sanofi Pasteur Inc.	1	$2,000
AbbVie(2 entities)	143	$1,811
Boehringer Ingelheim Pharma GmbH & Co.kg	5	$1,027
Novo Nordisk	53	$678
Bayer	42	$566
Amarin Pharma, Inc.	35	$498
Astellas Pharma US Inc	19	$404
Dexcom, Inc.	15	$328
Novartis	20	$258
Abbott	12	$231
Exact Sciences	13	$229
Takeda Pharmaceuticals U.S.A., Inc.	20	$196
Lilly USA, LLC	12	$193
Cequr Corporation	3	$192
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	11	$158
Xeris Pharmaceuticals, Inc.	9	$155
Teva Pharmaceuticals USA, Inc.	10	$144
Exeltis, USA Inc.	1	$140
Scilex Pharmaceuticals Inc.	9	$132
Biohaven Pharmaceuticals, Inc.	10	$130
Kowa Pharmaceuticals America, Inc.	7	$125
Johnson & Johnson	6	$101
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	6	$101
Biohaven Pharmaceutical Holding Company Ltd.	7	$100
Amphastar Pharmaceuticals, Inc.	5	$86
Mylan Specialty L.p.	6	$84
Otsuka America Pharmaceutical, Inc.	3	$73
Tempus AI, Inc	4	$61
E.r. Squibb & Sons, L.L.C.	3	$49
SK Life Science, Inc.	2	$44
Medtronic	2	$43
Sunovion Pharmaceuticals Inc.	5	$42
Shield Therapeutics Inc	2	$41
Phathom Pharmaceuticals, Inc.	2	$41
Mannkind Corporation	2	$38
Genentech, Inc.	1	$38
Neurelis, Inc.	2	$38
Lifescan, Inc.	2	$33
Sanofi-aventis U.S. LLC	2	$29
Insulet Corporation	1	$26
Hikma Pharmaceuticals USA	2	$25
Axsome Therapeutics, Inc.	1	$24
Pulmonx Corporation	1	$19
Mycovia Pharmaceuticals, Inc.	1	$17

How this compares

$2,204,546 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio →

Medicare billing

Part B allowed, 2024

$19,408

Medicare patients

Services billed

235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Dayton

Steve ChoiDayton$4.8M
Michael ButcherCincinnati$18.3M
William RandallKettering$7.5M
Paul NugentCincinnati$4.9M
Rajesh DavitCincinnati$2M
Kwabena OtengSpringdale$2M
Blaise GattoMoraine$1.8M
Cathy GreiweColumbus$1.4M
Brian BeesleyColumbus$1.4M
Thomas GraceFindlay$1.3M

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →